Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,832 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07490418Recruiting
Brain injury screening for mild head trauma or neurological symptoms
This trial tests a device (TES HT100) to screen for brain injuries in people with mild head trauma or certain neurological symptoms. It aims to quickly identify who might need imaging or follow-up care.
Castel Volturno, CEAges 18 years+ - NCT07490522Recruiting
Remote monitoring for gout in primary care
This study tests whether a smartphone app can help your doctor monitor your gout and adjust your urate-lowering medication. It is a feasibility study, meaning it checks if the approach works well for patients.
OsloAges 18 years+ - NCT07490613RecruitingPhase 1
Study of SHR-3836 for people with multiple myeloma
This trial tests a new drug called SHR-3836 for patients with multiple myeloma that has come back or stopped responding to treatment. The goal is to see if the drug is safe and how it works against the cancer.
Suzhou, JiangsuAges 18 years+ - NCT07491042Recruiting
A study of SGLT2 inhibitors for people on peritoneal dialysis
This study tests whether a type of diabetes medicine called SGLT2 inhibitors (which help lower blood sugar and protect the kidneys) can benefit people who are on chronic peritoneal dialysis. You may be able to join if you are 13 or older, have some urine output, and do not have certain other health issues.
NizwaAges 13 years+ - NCT07491185Recruiting
How blood sugar control affects brain oxygen and recovery in diabetic surgery patients
This study looks at how well-controlled blood sugar (measured by HbA1c) affects brain oxygen levels during urologic surgery and how it impacts recovery afterward. It compares diabetic patients to non-diabetic patients to understand the role of blood sugar control in surgical outcomes.
IzmirAges 18 years+ - NCT07491562Recruiting
Testing a neck brace for ALS-related neck weakness
This study tests a special neck brace (exoskeleton) designed to help people with ALS who have neck weakness. It will see if the device helps support your head and makes daily tasks easier.
Salt Lake City, UtahAges Any age - NCT07491848Recruiting
Mouth health study for hepatitis B and D patients
This study looks at mouth health in people with hepatitis B and D, including those taking a medicine called bulevirtide and those not taking it. It may help understand how these infections affect the mouth and gums.
CraiovaAges 18 years+ - NCT07491913Recruiting
Stopping biologic therapy for Takayasu arteritis in stable patients
This study looks at whether it is safe for people with Takayasu arteritis to stop taking their biologic medication (like TNF inhibitors or tocilizumab) if they have been in remission—meaning their disease has been quiet—for a long time. You might join this trial if your condition has been stable for years and you haven't needed steroids lately.
IstanbulAges 18 years+ - NCT07492511Recruiting
Ultrasound patterns in kidney and liver after trauma
This trial uses special ultrasound (Doppler) to look at blood flow in the kidneys and liver after a serious injury. It aims to find patterns that could help doctors better understand and treat trauma patients.
BolognaAges 18–65 - NCT07492537Recruiting
Helping with low mood after your first heart attack
This trial is for people who have just had their first heart attack and may be feeling some low mood or sadness. It aims to understand and help with these feelings early on, before they become a bigger problem.
Roma, ItaliaAges 18 years+ - NCT07492745Recruiting
Staying active during your hospital stay
This trial tests whether a simple reminder can encourage you to stay active while you are in the hospital. It aims to help older patients maintain their strength and independence during recovery.
BrusselsAges 50 years+ - NCT07493109RecruitingPhase 3
Maintenance treatment for hepatitis B-related lymphoma after initial therapy
This trial tests whether the drug chidamide, taken after initial successful treatment, can help prevent relapse in people with a type of lymphoma (diffuse large B-cell lymphoma) who also have chronic hepatitis B. Participants must have achieved complete remission after six cycles of standard chemotherapy (R-CHOP).
Changchun, JilinAges 18–80 - NCT07493135RecruitingEarly Phase 1
IMV102 for relapsed/refractory multiple myeloma
This early-phase trial tests an experimental drug called IMV102 for people with multiple myeloma that has come back or stopped responding to at least 3 prior treatments. The study aims to see if IMV102 is safe and how well it works.
BeijingAges 18–80 - NCT07493551Recruiting
Bioequivalence study of a long-acting injection for schizophrenia
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
Beijing, Beijing MunicipalityAges 18–65 - NCT07493642Recruiting
Video health program for chronic kidney disease patients
This trial tests whether watching educational videos about exercise and staying active can improve physical fitness for people with early to moderate chronic kidney disease. You can take part from home using a smartphone, tablet, or computer.
New Taipei City, Taishan DistrictAges 20 years+ - NCT07493876Recruiting
Enhanced recovery after surgery for peritoneal cancer
This trial tests a special recovery program after surgery for cancer that has spread to the lining of the belly. The program aims to help you heal faster and feel better after the procedure.
Candiolo, TurinAges 18 years+ - NCT07494201Recruiting
MIMICC study for people with colorectal cancer
This trial is studying patients with colorectal cancer who are scheduled for surgery. Researchers want to learn more about the cancer to improve future treatments.
Candiolo, Torino (TO)Ages 18–75 - NCT07494409RecruitingPhase 3
A new oral medicine for anemia in dialysis patients
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
ShanghaiAges 18–75 - NCT07496242Recruiting
Immune system study in desmoid fibromatosis patients
This study looks at the immune system of people with desmoid fibromatosis. It aims to understand how the immune system behaves in patients who are either watching their tumor (active surveillance) or getting treatment.
CandioloAges 18 years+ - NCT07496723Recruiting
Comparing diagnostic methods for appendicitis surgery
This trial looks at whether different ways of diagnosing appendicitis (like CT scans) are accurate. It's for people who already had surgery to remove their appendix and want to help doctors learn more.
Sanliurfa, ŞanlıurfaAges 18 years+ - NCT07497464Recruiting
Handedness test for stroke recovery
This trial tests if a simple, free task can recognize handedness in people who have had a stroke. It aims to help tailor rehabilitation after a stroke.
Madrid, MadridAges 18 years+ - NCT07497867Recruiting
Long-term study of Korean CADASIL patients
This study follows people with CADASIL over time to learn more about the condition. It may help researchers understand how CADASIL progresses and improve care for patients.
Jeju City, Jeju-doAges 19 years+ - NCT07498283Recruiting
Peer mentor support for atrial fibrillation
This study tests if having a peer mentor—someone who has been through similar health experiences—can help people with atrial fibrillation who have lower income or education levels. You would talk with a mentor and fill out surveys to see if this support improves your well-being.
Herlev, Capital RegionAges 18 years+ - NCT07498478RecruitingPhase 2
Tinengotinib and fulvestrant for advanced HR+ HER2- breast cancer
This trial tests a new drug called tinengotinib combined with the hormone therapy fulvestrant for people with HR-positive, HER2-negative breast cancer that has come back or spread. It is for those who have already tried a CDK4/6 inhibitor and at least one hormone therapy.
Guangzhou, GuangdongAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,832 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.